a $30m burn per q is concrete evidence that this exec team has no idea how to run a biz. $30m burn!!!! on what!!! salespople? hahahaha. $30m a q is what you spend when you are actually doing a phase 3 study for fda apporoval.... for a cancer drug!!!!!!!!!! LOSERS!!!!!!!! can't wait to see the carnage!
Yes we will hear all about these numbers on Monday's conference call, much news to enjoy in a few days...
Jeremy I noticed this morning before the open, that there were a lot of PUTS at 13.
Sorry I don't remember the number but it was alarming to me . The vast majority of the volume in those puts is now gone.
My point is may be some of the negative thoughts are going away with that early announcement.
This time I am not getting excited over an announcement. Sooner or later we get going and hopefully its Monday.
R U FOR REAL? It will be a standard conference call no big news...no hoopla...etc stop making it seem like it's the expected call. jeeezus!!!!!!!!!!!!!!!!!
Nice to hear from you. You were missed. The board is frustrating lately. 5 ignored posts for every valid welcome post. I'm glad to hear you are well and still in. Good luck with the move.
Sentiment: Strong Buy
We all know there is ONLY upside to this Conference Call......... news on accurate script numbers, news on formulary coverage expansion news on Medicare script expansion, news on European distribution plans, news on trial update--- news from Japan revenues from Torii........ only stuff to look forward to, naysayers below have different opinions, but the truth above remains
Well...after Mannkind (MNKD) got FDA approval, Goldman Sachs downgraded them to sell with a price target of $3. The stock was trading over $7. Now it's barely above $4.5, and that makes no sense either!!